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Interaction of cancer cells with diverse cell types in the tumor stroma is today recog-
nized to have a fate-determining role for the progression and outcome of human cancers.
Despite the well-described interactions of cancer cells with several stromal components,
i.e., inﬂammatory cells, cancer-associated ﬁbroblasts, endothelial cells, and pericytes, the
investigation of their peculiar relationship with neural cells is still at its ﬁrst footsteps.
Pancreatic cancer (PCa) with its abundant stroma represents one of the best-studied exam-
ples of a malignant tumor with a mutually trophic interaction between cancer cells and
the intratumoral nerves embedded in the desmoplastic stroma. Nerves in PCa are a rich
source of neurotrophic factors like nerve growth factor (NGF), glial-cell-derived neurotrophic
factor (GDNF), artemin; of neuronal chemokines like fractalkine; and of autonomic neuro-
transmitters like norepinephrine which can all enhance the invasiveness of PCa cells via
matrix-metalloproteinase (MMP) upregulation, trigger neural invasion (NI), and activate pro-
survival signaling pathways. Similarly, PCa cells themselves provide intrapancreatic nerves
with abundant trophic agents which entail a remarkable neuroplasticity, leading to emer-
gence of more routes for NI and cancer spread, to augmented local neuro-surveillance,
neural sensitization, and neuropathic pain.The strong correlation of NI with PCa-associated
desmoplasia suggests the potential presence of a triangular relationship between nerves,
PCa cells, and other stromal partners like myoﬁbroblasts and pancreatic stellate cells
which generate tumor desmoplasia. Hence, although not a classical hallmark of human
cancers, nerve-cancer interactions can be considered as an indispensable sub-class of
cancer-stroma interactions in PCa. The present article provides an overview of the so far
known nerve-cancer interactions in PCa and illustrates their ominous role in the stromal
biology of human PCa.
Keywords: stroma, pancreatic cancer, neural invasion, neurotrophic factors, neurotransmitters, neuropathic pain,
neuroplasticity, desmoplasia
INTRODUCTION
Lessons from cancer studies of the past decade have made an
important contribution to our understanding of the general fea-
tures of cancer by pointing out to the role of “tumor microenvi-
ronment” in cancer progression (Hanahan and Weinberg, 2000).
In the “next generation” of hallmarks of cancer, what is con-
sidered a new hallmark is the interaction of cancer cells with
apparently normal cells in their surroundings which potentiate
their own tumorigenic capacity (Hanahan and Weinberg, 2011).
These non-neoplastic cells acquire an activated state during can-
cer progression and maintain the continuous growth and spread
of the malignant tumor (Dvorak, 1986; Riss et al., 2006; Egeblad
et al., 2010). In most cases, these cells of the tumor microenviron-
ment belong to the tumor-associated inﬂammatory cells which
secrete growth factors, pro-angiogenic factors, and extracellular
matrix-degrading enzymes which sustain invasion and metastasis
(de Visser et al., 2006; de Visser, 2008). Hence, the logical role of
the immune system in the eradication of malignant cells seems
to be accompanied by a concomitant tumor-promoting property
of inﬂammation, especially for those cancer cells that can escape
from immune destruction (de Visser et al., 2006; de Visser, 2008;
DeNardo et al., 2010).
However, cancer cells undergo an exploitative interaction not
onlywith immune cells, but alsowith several other cell typeswhich
are present in their direct environment, termed stroma, i.e., inter-
stitium, of the organ of tumor origin (Dvorak, 1986; Pietras and
Ostman, 2010). Stroma, both in normal and neoplastic tissues,
is composed of non-cellular and cellular components (Dvorak,
1986; Pietras and Ostman, 2010; Hanahan and Weinberg, 2011).
The non-cellular part consists of deposits of large extracellular
matrix proteins like collagen, ﬁbronectin, laminin, etc. The cellu-
lar compartment comprises immune cells,ﬁbroblasts, vascular and
lymphatic endothelial cells,pericytes, and cells of peripheral nerves
(Dvorak, 1986; Pietras andOstman, 2010;Hanahan andWeinberg,
2011).All these cells have been the focus of investigation in the past
10 years due to their ability to promote tumor growth and metas-
tasis (Dvorak, 1986; Pietras and Ostman, 2010). In addition to the
above-mentioned role of immune cells, cancer-associated ﬁbrob-
lasts – or stellate cells as they are commonly referred to in the
pancreas and the liver – have been shown to provide cancer cells
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with numerous growth factors, cytokines, and matrix-degrading
enzymes which enhance the proliferation, invasion, and metasta-
sis of cancer cells (Vonlaufen et al., 2008b; Rasanen and Vaheri,
2010). Similarly, endothelial cells are increasingly recruited during
tumor angiogenesis, display distinct surface expression patterns
for growth factor receptors and allow for tumor nourishment
and dissemination (Nagy et al., 2010). As a novel niche of cancer
research, pericytes have gained attention as potential “gatekeepers”
in tumor metastasis due to their role as cells regulating vessel per-
meability and integrity (Raza et al., 2010; Hanahan andWeinberg,
2011).
Looking at the diversity of cells which have been studied in
the tumor stroma, an emerging cell type is represented by cells
of peripheral nerves. Although the study of their interaction with
cancer is still at its very beginning, the human cancer which proba-
bly reﬂects the highest degree of nerve-cancer interactions and has
thus been subject to most intense investigation is pancreatic can-
cer (PCa; Ceyhan et al., 2009b, 2010; Demir et al., 2010a). Termed
“ductal adenocarcinoma of the pancreas,” PCa as one of the most
aggressive human malignancies is characterized by pronounced
tumor desmoplasia, and the associated reduction in intratumoral
vessel density is considered the leading cause for the limited local
delivery of chemotherapeutics into the tumor (Olive et al., 2009).
In this “enlarged” microenvironment of PCa cells, what is a fre-
quent striking observation are the local nerve alterations in the
intra- and peritumoral tissue (Ceyhan et al., 2009a; Demir et al.,
2010a). Research from the past 10 years uncovered several crucial
features of nerve-cancer interactions inPCa, includingneural plas-
ticity, neural invasion (NI), and the associated neuropathic pain
syndrome in PCa (Ceyhan et al., 2009a; Demir et al., 2010a). Just
like increased appreciation of the role of the members of tumor
stroma, neural cells are increasingly perceived as major modula-
tors of tumor growth and spread (Entschladen et al., 2008). The
present review aims at providing an overview of the so far elu-
cidated interactions of intrapancreatic nerves with PCa cells and
with other members of the pancreatic tumor stroma and raises
several important questions related to these exciting interactions.
NERVE-DERIVED FACTORS ENHANCE PANCREATIC CANCER
CELL INVASIVENESS
A possibility for nerves to inﬂuence the growth of PCa was con-
sidered in conjunction with the frequently observed invasion of
nerves by PCa cells (Zhu et al., 1999, 2001). This NI – or often
denoted as perineural invasion due to the frequent alignment of
PCa cells around the perineurium – is encountered in nearly 100%
of PCa cases upon targeted histopathological inspection of surgi-
cal specimens (Hirai et al., 2002; Liu and Lu, 2002; Ceyhan et al.,
2009a; Demir et al., 2010a; Bapat et al., 2011). In addition to being
another route of cancer spread,NI bears amajor clinical relevance:
it is considered the foremost reason for local tumor recurrence
after curative resection and correlates to the abdominal pain sen-
sation of PCa patients (Kayahara et al., 1991, 1993, 1995; Ozaki
et al., 1999). In an effort to address the pathogenesis of NI in PCa,
Zhu and Friess et al. investigated the expression of the best known
nerve-derived growth factor, i.e., nerve growth factor (NGF), in
humanPCa,motivated by the previously shownproliferative effect
of NGF upon lung cancer, prostate cancer, and glioblastoma cells
(Zhu et al., 1999, 2002). They could identify a close correlation
with intratumoral NGF expression, the frequency of NI, and the
degree of pain (Zhu et al., 1999). Subsequent studies showed that
NGF and its receptors TrkA and p75NTR are expressed not only
by nerves, but also by PCa cells themselves, making them respon-
sive to autocrineNGF signaling andparacrineNGF effects upon its
release from intrapancreatic nerves (Zhu et al., 2002; Ceyhan et al.,
2010). Indeed, supplementation of NGF into the growth medium
of PCa cells or stable NGF-transfection into PCa cells exerts a
prominent enhancer effect upon proliferation and invasiveness of
PCa cells (Zhu et al., 2001, 2002).
This demonstration of tumor-supporting effects of nerve-
derived factors like NGFwas followed by analysis of further neural
factors in terms of their similar capabilities. Particularly,members
of the glial-cell-derived neurotrophic factor (GDNF) family like
GDNF and artemin have also been shown to increase the inva-
sive capabilities of PCa cells (Figure 1; Funahashi et al., 2003,
2005; Okada et al., 2003; Takahashi et al., 2004; Zeng et al., 2008).
For GDNF, the mechanisms of this tumorigenicity have been
addressed in several studies. Especially, GDNF has been shown
to activate phosphatidylinositol 3-kinase (PI3-K)/Akt, extracellu-
lar signal-regulated kinase (ERK; Veit et al., 2004), and nuclear
factor kappa B (Takahashi et al., 2004) over RET activation and to
increase the expression of matrix-metalloproteinases type 2 and
9 as direct mediators of invasion (Okada et al., 2003, 2004). The
common observation in these studies is the prominent impact of
neurotrophic factors upon the invasiveness of PCa cells, with an
occasionally detected enhancement of proliferation. However, the
evenmore important deduction is the capability of nerves to inﬂu-
ence and actually enhance PCa spread, just like other components
of the tumor stroma.
NERVES AND PANCREATIC CANCER CELLS UNDERGO A
MUTUALLY TROPHIC INTERACTION
The expression of neurotrophic factors by PCa cells and nerves at
the same time implies that PCa cells may make use of the same
repertoire of trophic signals as nerves do. Hence, once in prox-
imity, these two cell types would potentially establish a mutually
beneﬁcial relationship. Indeed, this relationship is best seen in
invasion of nerves by PCa cells (Ceyhan et al., 2008a). Although
PCa cells have been postulated to damage nerves during this pecu-
liar invasion process (Bockman et al., 1994), surgical pathologists
have steadily observed extension of PCa cell colonies along intra-
pancreatic nerves toward extrapancreatic neural plexus (Kayahara
et al., 1991, 2007). Therefore, a true “destruction” of nerves by
PCa cells has not been conclusively conﬁrmed, and actually, sev-
eral in vitro studies provide evidence for the exact opposite: in the
past 10 years, several groups aimed at establishing novel in vitro
and in vivo models with the aim of simulating NI in PCa (Eibl
and Reber, 2005; Dai et al., 2007; Ceyhan et al., 2008a; Gil et al.,
2008, 2010). These studies typically harbor heterotypic cell cul-
ture settings where PCa cells and neurons, usually derived from
rodent dorsal root ganglia (DRG), are confronted with each other
and observed for their interaction (Gil et al., 2010). In all these
settings, researchers repeatedly detected targeted migration of
PCa cells toward neurons, which extend their neurites toward
the migrating PCa cells. Once together, PCa cells continue their
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FIGURE 1 | Nerve-cancer interactions in human pancreatic cancer (PCa).
Neural cells and PCa cells undergo a mutually growth-supporting interaction.
Nerve-derived molecules like neurotrophic factors, neurotransmitters, and
chemokines are capable of enhancing PCa cell tumorigenicity in several
aspects, including invasiveness, cancer cell chemotaxis, locomotion,
proliferation, and cell survival via upregulation of numerous signaling
pathways. In analogy, PCa cells secrete neuromodulatory agents which induce
neuroplasticity, augment neural invasion, and neuropathic pain sensation.
NGF, nerve growth factor; GDNF, glial-cell-derived neurotrophic factor;
Nf-kappaB, nuclear factor kappa B; PI3-K, phosphoinositide-3-kinase; nAChR,
nicotinic acetylcholine receptor; CREB, cAMP response element-binding; AKT,
protein kinase B; MMP-2 and -9, matrix-metalloproteinase-2 and -9; FAK, focal
adhesion kinase; Erk, extracellular signal-regulated kinase; MALT1,
mucosa-associated lymphoid tissue lymphoma translocation gene 1; TRAF,
tumor-necrosis-factor-receptor-associated factor; KIF14, kinesin family
member 14 (KIF14); ARHGDIbeta, RHO-GDP dissociation inhibitor-β; GAP-43,
growth-associated protein 43. Please refer to the manuscript for the
respective references.
migration along the DRG neurites, resembling a cell–cell adhesion
(Dai et al., 2007; Ceyhan et al., 2008a; Gil et al., 2010). In one
of these studies, a clear growth advantage, i.e., increased prolif-
eration and colony of formation, was shown for PCa cells which
built contacts with DRG neurites (Dai et al., 2007). Similarly, the
density of DRG neurites signiﬁcantly increased toward migrat-
ing PCa cell colonies (Dai et al., 2007; Ceyhan et al., 2008a).
Further evidence for this mutual growth support was found in
the upregulation of pro-survival genes, i.e. mucosa-associated
lymphoid tissue lymphoma translocation gene 1 (MALT1) and
tumor-necrosis-factor-receptor-associated factor (TRAF), in PCa
cells which were confronted with DRG neurons (Figure 1; Dai
et al., 2007). Thus, neural cells are today considered to be a fur-
ther cancer-supporting cell in PCa stroma andmicroenvironment
(Demir et al., 2010a). Importantly, nerves beneﬁt from this effect
also for their own growth advantage since PCa cells can also pro-
vide them with the same trophic signals (Demir et al., 2010a).
Hence, nerve-cancer interactions in PCa stroma represent another
major example of an“unholy alliance” in PCa, as previously shown
for other stromal cells (Vonlaufen et al., 2008b).
NERVES MEDIATE ENHANCED PANCREATIC CANCER CELL
CHEMOATTRACTION AND MOTILITY
For the mutually trophic interaction between nerves and can-
cer cells to occur, nerves and PCa cells must exchange signals to
ensure their proximity. These signals would typically constitute
agents with chemoattractive attributes. In this context, the abun-
dance of neurotrophic signals in nerves and in PCa cells them-
selves represents not only a trophic support, but actually also a
major mechanism of mutual chemoattraction due to the intrinsic
chemoattractive properties of neurotrophins and GDNF family of
neurotrophic factors (Tang et al., 1998; Paratcha et al., 2006; Zhou
et al., 2007; Cornejo et al., 2010; Mwizerwa et al., 2011). These
factors are known to be chemotactic upon neuronal precursors,
cerebellar cell precursors, glia cells, and enteric neural crest pre-
cursors (Tang et al., 1998; Paratcha et al., 2006; Zhou et al., 2007;
Cornejo et al., 2010; Mwizerwa et al., 2011). Furthermore, neu-
rons from GDNF-knockout mice have reduced ability to attract
PCa cells (Gil et al., 2010). Hence, neurotrophic factor secretion
from intrapancreatic nerves and the associated chemoattraction
of PCa cells toward nerves is assumed to be one of the initiat-
ing events in the nerve-cancer interactions and the entailing NI
(Ceyhan et al., 2006, 2008a; Demir et al., 2010a).
Besides neurotrophic factors, there is recent evidence for PCa
cell recruitment toward nerves viamore classical chemoattractants
like chemokines. The chemokine proﬁle of nerves is still subject
to further investigation. However, one of the well-characterized
neuronal chemokines, fractalkine, bears the unique feature of
possessing a single and speciﬁc receptor, i.e., CX3CR1, which
has recently been demonstrated to be expressed on PCa cells
(Marchesi et al., 2010). In detail, PCa cell lines which express
CX3CR1migrate and adhere to neuroblastoma cells, a process that
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involves beta1-integrin receptors and activation of focal adhesion
kinase (Marchesi et al., 2010). In vivo, transfection of MiaPaCa2–
PCa cells with CX3CR1 results in increased subcutaneous NI in
nude mice (Marchesi et al., 2010). Moreover, increased CX3CR1
expression in PCa tissues is strongly associated with more promi-
nent NI and earlier local tumor recurrence (Marchesi et al., 2010).
Overall, these ﬁndings provide strong evidence for a key role of
chemokine signaling in the mutual attraction of nerves and PCa
cells and their resulting interaction (Figure 1). Further studies on
the role of other chemokines in the nerve-cancer attraction in PCa
are still lacking.
In accordance with the tumor-attractive properties of nerves,
PCa cells respond to these neural signals by upregulation of their
locomotor machinery (Abiatari et al., 2009a,b,c). In an ex vivo NI
model, Abiatari et al. (2009a) determined the transcriptome pro-
ﬁle of PCa cells which were co-cultivated with explanted rat vagal
nerves. Under these conditions, PCa cell clones which showed NI
were compared to non-invasive clones in terms of their differen-
tially regulated genes. Here, the investigators identiﬁed increased
expression of kinesin family member 14 (KIF14) and RHO-GDP
dissociation inhibitor-β (ARHGDIbeta), and the siRNA-mediated
speciﬁc knockdown of these cytoskeletal molecules signiﬁcantly
inhibited NI (Abiatari et al., 2009a). In a subsequent study, the
same group identiﬁedmicrotubule-associated proteinRP/EB fam-
ily member 2 (MAPRE2) as another factor which is overexpressed
by neural invasive PCa cell clones and associated with worse sur-
vival rates in PCapatients (Figure 1;Abiatari et al., 2009b).Overall,
these studies underline the importance of PCa motility factors in
the generation of NI and clearly show that intrapancreatic nerves
are capable of strongly contributing to the local tumor progression
in PCa by chemo-attracting PCa cells and activating their locomo-
tion. Therefore, based on our knowledge to date, nerves solely have
tumor-promoting effects in PCa and are therefore one of the “best
partners in crime” for PCa cells (Legg, 2011).
NERVE-CANCER INTERACTIONS IN PANCREATIC CANCER
INDUCE NEUROPLASTICITY AND NEUROPATHIC PAIN
The tumor-promoting effects of nerves in PCa and the trophic
support of PCa cells for nerves result in complex neuroplastic
alterations in the PCa stroma. When analyzed systematically, PCa
specimens frequently harbor increased neural density and intra-
pancreatic neural hypertrophy (Figure 2; Ceyhan et al., 2009a;
Demir et al., 2010a). Furthermore, this neuroplasticity is encoun-
tered in no other pancreatic tumor, either benign or malignant,
at this extent as seen in PCa (Ceyhan et al., 2009a; Demir et al.,
2010a). Growth-associated-protein-43,which is known to be over-
expressed following neural damage or after long-term potenti-
ation in the brain, is much more prevalent in PCa tissue than
in the normal pancreas or other pancreatic tumor entities (Cey-
han et al., 2009a; Demir et al., 2010a). Recently, these alterations
have been demonstrated to be present in the apparently normal
pancreatic tissue adjacent to the pancreatic tumor, where a spe-
ciﬁc upregulation of NGF and artemin have been observed within
intrapancreatic nerves (Ceyhan et al., 2010).
In order to enable functional studies on the pathomechanism
of this neuroplasticity, a recent novel in vitro neuroplasticity assay
was established (Demir et al., 2010b).Here, neurons fromdifferent
FIGURE 2 | Neural invasion and neuroplasticity in the desmoplastic
PCa stroma. Human PCa specimens contain hypertrophic nerves which
are victims of neural invasion and frequently encountered in the
desmoplastic tumor stroma. The asterisks demonstrate nerves surrounded
by invading PCa cells in the activated perineural, immunolabeled tumor
desmoplasia (A,B). This neural invasion is either present as perineural
invasion (C) along their epi- or perineurium, or as endoneural invasion which
destructs the neural integrity (D).
sources, i.e., sensory neurons from DRG and myenteric neurons
of the Auerbach’s plexus, have been cultivated under conditions
resembling PCa tissue, particularly within PCa tissue extracts or
within supernatants of human PCa cell lines (Demir et al., 2010b).
Interestingly, these media exert a potent neurotrophic effect upon
neurons as they signiﬁcantly increase their neurite density, axonal
branching capacity, and entail a perikaryonal hypertrophy (Demir
et al., 2010b). Hence, novel functional studies help to recapit-
ulate the major characteristics of pancreatic neuroplasticity in
human PCa.
Besides being a remarkable example of disease-associated vis-
ceral neuroplasticity, these alterations seem to bear a unique asso-
ciation with the generation of the pain in PCa. Indeed, neural
hypertrophy is particularly detected in patients with increasing
severity of pain sensation (Ceyhan et al., 2009a). This association
becomes further interesting when considered in the context of
above-described, mutually trophic nerve-cancer cell interactions.
As seen under in vitro co-culture conditions, NI and pain sensa-
tion of PCa patients correlate to neural hypertrophy and increased
neural density in the PCa tissue (Ceyhan et al., 2009a). Therefore, it
seems that the mutually trophic interaction between PCa cells and
nerves has a major role in the generation of the pain in PCa. Based
on these multifold interactions, but also due to the previously
reported nerve damage which can be detected upon ultrastruc-
tural analysis of PCa tissues, pain in PCa is increasingly considered
to be of neuropathic origin (Ceyhan et al., 2008b, 2009a, 2010;
Demir et al., 2010a). While neuropathic pain medications are not
in common use to treat PCa-associated pain, minimally invasive,
interventional techniques like celiac plexus neurolysis or thoracic
splanchnicectomywhich intervene with the transmission of ongo-
ing pain stimuli from the periphery, i.e., the cancerous pancreatic
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tissue, have been proven to be effective to treat neuropathic pain
in advanced PCa (Stefaniak et al., 2005; Yan and Myers, 2007).
Intriguingly, emergence of pain as a result of nerve-cancer inter-
actions in PCa raises important questions related to the biological
signiﬁcance of pain sensation in these patients. Normally, pain
serves as a natural warning signal for the central nervous system,
alarming the presence of a noxious process in the organ of origin
(Fregni et al., 2007). Hence, the reactive response of the organism
to this stimulus would be to activate noxi-clearing surveillance
agents like inﬂammation (Fregni et al., 2007). However, in fact,
PCa cells do not seem to be subject to any disadvantage out of this
signaling: indeed, neuropathic pain sensation in PCa is associated
with much worse survival when compared to its absence (Ceyhan
et al., 2009a). This observation suggests that the pain-generating
events which seem to be initiated by PCa cells eventually yield
further support for PCa cells in their local and systemic spread.
Hence, an “unintended” tumor-promoting character may not be
unique to the direct microenvironment of the tumor within the
pancreatic tissue, but may also be a feature of distant homeostatic
organ systems like the central nervous system. This possibility as
clearly observed in the context of PCa deserves future investigation
to elucidate the contribution of “pain” to the biology of cancer.
NEUROTRANSMITTERS MODULATE PANCREATIC CANCER
CELL BIOLOGY
To what extent the nervous system can inﬂuence disease states has
long been an issue of debate. Interestingly, early studies already
demonstrated that antagonism of the sympathetic nervous system
and parasympathomimetic agents are capable of ameliorating the
course of experimental cancer, including chemically induced gas-
tric cancer and colon cancer (Tatsuta et al., 1988, 1989a,b, 1990,
1992). In the era of research on oncogenic pathways and genetic
deciphering, the modulatory role of nervous system upon can-
cer biology seems to have been somewhat neglected. Interestingly,
there has been a revival of interest in cancer neuromodulation,
owing to the discovery of neurotransmitter receptors on cancer
cells (Schuller et al., 2001, 2008a,b; Weddle et al., 2001; Al-Wadei
and Schuller, 2009; Al-Wadei et al., 2009b). In particular, can-
cer cells of the lung, colon, and pancreas have been shown to
express nicotinic and muscarinic acetylcholine receptors of the
parasympathetic nervous system, and the beta-adrenergic recep-
tors of the sympathetic nervous system (Schuller et al., 2001;
Wong et al., 2007; Schuller, 2008; Pettersson et al., 2009; Wu
et al., 2011). In this context, the ability of nitrosamines which
are constituents of tobacco to activate nicotinic acetylcholine
receptors (nAChRs) and induce enhanced cancer cell prolifer-
ation and invasiveness has been crucial for our understanding
of the association between tobacco smoking and carcinogene-
sis (Schuller, 2008). These studies demonstrated that activation
of α3, α5, and α7-nAChRs leads to intracellular phosphorylation
of growth-supporting pathways like CREB, ERK, Src, and AKT
(Al-Wadei et al., 2011). Hence, in contrast with earlier studies
where systemic administration of parasympathomimetics inhib-
ited cancer progression, these studies showed that activation of
cholinergic receptors may actually also lead to enhanced can-
cer cell growth (Schuller and Al-Wadei, 2010; Al-Wadei et al.,
2011). These at ﬁrst glance paradoxical ﬁndings reached recent
harmony in the studies by Al-Wadei et al. (2011) who showed
the cross-talk of beta-adrenergic signaling with nicotine-induced
activation of nAChRs in PCa. Indeed, activation of these recep-
tors results in the release of cellular stress-neurotransmitters which
bind to beta-adrenergic receptors in an autocrine fashion and acti-
vate tumorigenic signaling pathways (Al-Wadei et al., 2011). In
accordance, administration of propanolol, a non-selective beta-
adrenergic receptor blocker, results in attenuation of experimental
PCa (Al-Wadei et al., 2009a), whereas chronic neuropsycholog-
ical stress exacerbated the tumor via increased systemic cathe-
cholamine levels and subsequent activation of nAChRs (Schuller
et al., 2011). Similar growth-promoting effects have also been
demonstrated for acetylcholine which can signiﬁcantly increase
the proliferation and invasive ability of, e.g., colon cancer cells
(Cheng et al., 2008; Pettersson et al., 2009; Xie et al., 2009). More-
over, there is increasing evidence that the autonomic nervous
system may also inﬂuence tumor angiogenesis. Increased stress
was demonstrated to lead to increased angiogenesis in a murine
model of ovarian carcinoma through vascular endothelial growth
factor (VEGF) upregulation (Thaker et al., 2006; Lee et al., 2009;
Tilan and Kitlinska, 2010). Conversely, the norepinephrine pre-
cursor dopamine was shown inhibit angiogenesis by prevention
of VEGF receptor phosphorylation andmitogen-activated protein
kinase phosphorylation (Asada et al., 2008). In conjunction with
the tumor-promoting properties of tobacco smoking,nicotinewas
shown to increase neo-vascularization over nAChRs in, e.g., lung
cancer and gastric cancer (Natori et al., 2003; Shin et al., 2004;
Jarzynka et al., 2006). In colon cancer, it was shown that 5-HT
can support tumor angiogenesis by reduction of MMP-12 expres-
sion in tumor-associatedmacrophages, decreasing the levels of the
anti-angiogeneticmediator angiostatin (Nocito et al., 2008). So far,
similar data from the angiogenetic properties of neurotransmitters
in PCa are lacking. Still, it was previously demonstrated that the
naturally occurring perivascular sympathetic nerve ﬁbers are lost
around intratumoral vessels in PCa, suggesting a potential neural
dysregulation around tumor neo-vascularization (Ceyhan et al.,
2009b). Overall, it becomes increasingly clear that neurotransmit-
ters, whether from the sympathetic or parasympathetic nervous
system, can remarkably enhance PCa cell growth, angiogenesis,
andmetastasis by augmenting the release of growth factors, angio-
genetic factors, and pro-inﬂammatory cytokines (Schuller, 2008;
Schuller and Al-Wadei, 2010). Therefore, owing to all these recent
studies, neurotransmitters are likely to be an ongoing focus of
investigation in future studies on the interaction of PCa with
the primary source of these neurotransmitters in its stroma, i.e.,
intrapancreatic nerves. However, what deserves particular atten-
tion in this regard is the recently demonstrated remodeling of the
pancreatic autonomic innervation in PCa (Ceyhan et al., 2009b).
Analysis of nerve ﬁber qualities in PCa revealed that both sympa-
thetic and cholinergic nerve ﬁbers are prominently suppressed as
part of the neuroplastic alterations in the pancreas (Ceyhan et al.,
2009b). This “neural remodeling” implies that the local activity of
the autonomic nervous system may be subject to an inhibition,
which is why studies on the effect of (autonomic) neurotransmit-
ters on PCa cells and in murine PCa models which do not reﬂect
pancreatic neuroplasticity should be interpreted and translated
cautiously.
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THE “THIRD PARTY” IN NERVE-CANCER INTERACTIONS:
DESMOPLASIA AND PANCREATIC STELLATE CELLS
The above-described neural alterations in PCa suggest that the
direct interaction of PCa cells with nerves can bring about
increased neural density, neural hypertrophy, and NI by PCa cells
via neurotrophic factor and chemokine signaling. The possibility
of other agents or even other cell types which may play a medi-
ator role in the interaction between nerves and PCa cells has so
far not been genuinely considered. This possibility rises out of
recent observations on the actual localization of such alterations
within the PCa tissue. In detail, there is a ﬁrm correlation between
the degree of tumor desmoplasia and the severity of NI in PCa
(Ceyhan et al., 2009a; Figure 2). This observation underlines that
desmoplasia may be a factor triggering increased PCa cell inva-
siveness and thus NI. Desmoplasia, i.e. increased production of
dense extracellular matrix around tumor cells, is a hallmark of
PCa (Erkan et al., 2008, 2010; Olive et al., 2009; Pandol et al.,
2009). It is estimated that over 80% of the actual tumor mass
in PCa consists of tumor desmoplasia (Erkan et al., 2010). The
key role of tumor desmoplasia on the biology of PCa is best repre-
sented by ﬁndings from recent studies targeting signaling pathways
which contribute to the generation of tumor desmoplasia. These
studies convincingly demonstrated enhanced chemotherapeutic
agent delivery into the tumor and improved survival upon deple-
tion of PCa-associated desmoplasia upon Hedgehog inhibition
in transgenic mouse models of PCa (Olive et al., 2009). In the
past decade, research on PCa-associated desmoplasia turned its
focus onto the role of cancer-associated myoﬁbroblasts in PCa,
i.e., pancreatic stellate cells (PSCs), which have been shown to
be the foremost producer of tumor desmoplasia in their acti-
vated state (Apte et al., 1998; Haber et al., 1999; Apte and Wilson,
2004). Besides producing extracellular matrix components like
type I collagen, ﬁbronectin and periostin, these cells represent
another major tumor growth-promoting cell type in the PCa
microenvironment (Omary et al., 2007; Vonlaufen et al., 2008b).
Particularly, PSCs produce growth factors like PDGF which can
increase the proliferation of PCa cells, and induce epithelial–
mesenchymal transition (EMT) in PCa cells and thereby enhance
their invasiveness via transforming growth factor-β (Omary et al.,
2007). Moreover, PSCs have also been shown to inﬂuence tumor
angiogenesis by augmenting the endostatin production of PCa
cells under co-culture and by increasing their own VEGF secre-
tion under hypoxia (Erkan et al., 2009). In accordance with
these tumorigenic properties of PSCs, Vonlaufen et al. (2008a)
demonstrated increased tumor size, metastasis, and desmoplasia
in athymic mice which were co-injected with human PSCs and
PCa cells as opposed to solitary injection of PCa cells. Further-
more, co-injected PSCs were also observed to readily extravasate
during themetastatic spread of the pancreatic tumor and the asso-
ciated angiogenesis (Xu et al., 2010). There is further evidence that
PCa cells which are treated with PSCs-conditioned medium are
more resistant to chemotherapy with gemcitabine or to radio-
therapy (Hwang et al., 2008). Interestingly, PSCs can also secrete
high levels of matrix-metalloproteinase-2, even much higher than
the level produced by PCa cells, thereby potentially enhancing
their in-tissue invasiveness (Schneiderhan et al., 2007). Overall,
the tumor-promoting effects of PSCs represent one of the leading
“unholy” interactions in PCamicroenvironment (Vonlaufen et al.,
2008b).
As cells which are particularly important for the aggressive
behavior of PCa cells, PSCs have recently been subject to investiga-
tion in terms of their interaction with stromal nerves (Figure 3).
Particularly, there is increasing evidence for the presence of intrin-
sic neurotrophic attributes of PSCs (Demir et al., 2010b). In an
in vitro neuroplasticity model, PSCs derived from human chronic
pancreatitis tissues could prominently enhance the neurite out-
growth of isolated DRG neurons and myenteric plexus cells. Even
though this neurotrophic effect was not achieved by supernatants
of PSCs fromPCa,PSCs derived fromPCa could noticeably induce
dense neural networks among isolated DRG neurons and increase
their neurite density (Demir et al., 2010b). This important effect
could not be seen in PSCs derived from chronic pancreatitis
patients. However, studies using PSCs derived from human patho-
logical tissues bear the assumption that these cells preserve their
in-tissue expression and secretory proﬁles after their isolation and
in vitro cultivation. Therefore, in vitro studies on isolated PSCs
may not allow a conclusive statement on the actual neurotrophic
potential of PSCs within PCa tissue. The possibility of PSCs as a
FIGURE 3 |The hypothetic triangular relationship between nerves, PCa
cells, and pancreatic stellate cells (PSC). PCa cells beneﬁt not only from
nerves, but also from PSCs which can – in their activated state – increase
PCa cell growth, invasiveness, and tumor angiogenesis. Moreover,
activated PSCs can provide neural cells with neurotrophic factors like NGF
and neurotransmitters which can modulate neuronal activity. Conversely,
there is yet insufﬁcient evidence for a modulating activity of nerve-derived
molecules upon PSC activity. Still, studies on hepatic stellate cells
demonstrated that neurotransmitters including 5-hydroxytryptophan (5-HT),
neuropeptideY, gamma-amino butyric acid (GABA), and acetylcholine (ACh)
can signiﬁcantly increase the ﬁbrogenic activity, proliferation, and calcium
currents of stellate cells. Right upper image: myenteric plexus neurons
treated with neurotrophic PCa tissue extracts, immunostained against the
neuronal marker beta-III-tubulin. Lower image: rat pancreatic stellate cells
immunostained against alpha smooth muscle actin. PDGF, platelet-derived
growth factor; VEGF, vascular endothelial growth factor; MMP,
matrix-metalloproteinase; ACh, acetylcholine; NGF, nerve growth factor;
5-HT, 5-hydroxytryptophan; NPY, neuropeptideY; GABA, gamma-amino
butyric acid; ECM, extracellular matrix; GDNF, glial-cell-derived neurotrophic
factor. Please refer to the manuscript for the respective references.
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producer of neurotrophic agents has recently been demonstrated
by Haas et al. (2009) who could show increased NGF production
over ALK5-activiation following stimulation of PSCs with TGF-β.
Similarly, PSCs from chronic pancreatitis tissues also upregulate
their expression of the neurotrophic factor artemin when exposed
to TGF-β (Ceyhan et al., 2007). While such a neurotrophic factor
upregulation may well inﬂuence PCa cell invasiveness, prolifera-
tion, and contribute to local repair/regenerative processes, its exact
contribution to intrapancreatic neuroplastic alterations remains
to be determined, especially in the absence of any major cor-
relation of desmoplasia to neural density, size, and pancreatic
neuro-inﬂammation (pancreatic neuritis) in PCa (Ceyhan et al.,
2009a). In fact, desmoplastic tissue areas in PCa have even been
shown to exhibit a loss of the normal parenchymal nerve ﬁber net-
work within the dense tumor stroma (Samkharadze et al., 2011).
Still, this loss of small-caliber nerves ﬁbers was accompanied by
the emergence of hypertrophic, GAP-43-immunoreactive nerves
embedded in the tumor stroma (Samkharadze et al., 2011). At this
point, it should be considered that PSCs, in particular the abun-
dant ECMcomponents that theyproduce inPCa stroma,may exert
a strong trophic effect upon neurons and their nerve ﬁbers. It is
well established that ECM components like collagen, laminin, and
ﬁbronectin can considerably enhance neurite formation by neu-
rons (Fujii et al., 1982). For example, on type I collagen or heparan
sulfate-collagen surfaces, neurons build dense neuronal networks
as opposed to dermatan sulfate (DS), chondroitin-6-sulfate (C6S),
or hyaluronic acid (HA)-bound collagen substrates. Interestingly,
it was shown that neurites avoid surfaces coated with DS, C6S, or
HA in order to remain in contact with collagen (Fujii et al., 1982).
In chick embryo explants, collagen types I and III supported neu-
ritogenesis at least as efﬁciently as laminin, whereas this effect was
less pronounced for collagen type V and absent for types II, IV,
and VI (Carri et al., 1992). Considering the abundant production
of collagen type I by activated PSCs, it is conceivable that this par-
ticular stroma in PCa may be one of the leading factors in the
neural sprouting and neural hypertrophy in PCa. The exact phe-
notype of these “novel” nerve ﬁbers is still subject to investigation.
Nevertheless, these sprouting large nerve trunks were shown to
undergo the above-mentioned remodeling, characterized by sup-
pression of sympathetic and cholinergic nerve ﬁbers, especially
in nerves which are invaded PCa cells (Ceyhan et al., 2009b).
Moreover, this suppression was also identiﬁed to be even more
prominent in tissues derived from PCa patients who reported to
have abdominal pain (Ceyhan et al., 2009b). Hence, in this remod-
eling process where neurons alter their chemical code, it seems
that at the interface of the interaction between PSCs and neurons,
there is a suppression of autonomic nerve ﬁbers. The functional
implications of this neural remodeling in the desmoplastic tumor
stroma in PCa remain to be elucidated.
While these ﬁndings suggest a potential, at least indirect inﬂu-
ence of desmoplasia upon pancreatic neuropathy in PCa, there
is recent evidence for a direct cross-signaling between PSCs and
nerves, as PSCs have been demonstrated to release acetylcholine
(ACh), the main parasympathetic neurotransmitter (Figure 3;
Phillips et al., 2010). Strikingly, PSCs possess the complete cel-
lular ACh synthesis and release machinery which can get activated
by cholecystokinin (CCK; Phillips et al., 2010). Owing to this
neurotransmitter, PSCs can induce amylase secretion from pan-
creatic acini (Phillips et al., 2010). Besides demonstrating a novel
mechanism for CCK-induced exocrine secretion in pancreas, this
study points out to the profound ability of PSCs to directly interact
with intrapancreatic nerves (Phillips et al., 2010).
The extent of interactions of PSCs with neural cells, in particu-
lar with neurons has not yet been to subject to detailed investiga-
tion. On a theoretical basis, seeing the ACh production by PSCs,
one can imagine that PSCs may similarly possess receptors for
nerve-derivedmolecules, in particular for a large battery of neuro-
transmitterswhich are produced by intrinsic pancreatic neurons as
derivatives of myenteric neurons (Figure 3). These neurotransmit-
ters include calcitonin-gene-related-peptide (CGRP), vasoactive
intestinal peptide (VIP), substance P, 5-hydroxytrytophan (5-HT),
acetylcholine, and norepinephrine. It has to be underlined that
the presence of the respective receptors for these neurotransmit-
ters has not yet been demonstrated in PSCs. However, research on
liver ﬁbrogenesis has delineated the presence of several of these
receptors on hepatic stellate cells (HSCs). It is known that HSCs
can build calcium currents and thus get activated by 5-HT via the
5HT2 receptor (Park et al., 2011). Furthermore, rat and human
HSCs possess the 5-HT1B, 5-HT1F 5-HT2A 5-HT2B, and 5-HT7
receptors, where 5-HT2B was shown to closely correlate to the
degree of ﬁbrosis in experimental liver ﬁbrosis induced by car-
bon tetrachloride (Ruddell et al., 2006). Conversely, the GABA(B)
receptor agonist baclofen can inhibit the myoﬁbroblastic differ-
entiation, ECM production, and TGFβ1-secretion by HSCs (Xiao
et al., 2010). For adrenergic signaling, it was shown that activated
human HSC express alpha(1A)-adrenoceptors which can lead to
rapid calcium currents following norepinephrine-induced acti-
vation (Sancho-Bru et al., 2006). Moreover, norepinephrine can
induce phosphorylation of myosin light chain II, contraction of
HSCs and promote the secretion of pro-inﬂammatory cytokines
from HSCs (Oben and Diehl, 2004; Oben et al., 2004; Sancho-
Bru et al., 2006). A similar support of proliferation for HSCs was
also reported for neuropeptide Y and acetylcholine (Oben et al.,
2003a,b). Overall, even though similar data fromPSCs aremissing,
the multitude of previously demonstrated effects of neurotrans-
mitters upon HSCs suggests that a similar neuromodulation may
also well exist for PSCs. Moreover, a very recent study on the inter-
convertibility of ﬁbroblast-like cells and neurons (Yoo et al., 2011)
adds another dimension to this exciting interaction, implying a
potentially direct contribution of PSCs to pancreatic neuroplastic-
ity in PCa. However, whether such microRNA signals are indeed
present in PCa tissue (Yoo et al., 2011), and whether intrapan-
creatic myoﬁbroblast-like cells can generate neurons of extrinsic
origin (i.e., residing in DRG) which represent the most likely
source of neuroplasticity, remain an issue of debate. Regarding
all these novel ﬁndings and as suggested by the consensus report
from a recent consensus conference on PSC research (StellaTUM),
future studies are awaited that shall elucidate the interactions of
PSCs with the peripheral nervous system in the pancreas (Erkan
et al., 2011).
SUMMARY AND CONCLUSION
Tumor stroma in PCa harbors a wide spectrum of cells which,
in their adaptive response to carcinogenesis and tumor growth,
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activate signaling mechanisms that paradoxically promote tumor
invasion and metastasis. Despite remarkable advances in our
understanding of the interaction of PCa cells with stromal ﬁbrob-
lasts, endothelial cells, pericytes, and inﬂammatory cells, nerve-
cancer interactions in PCa still deservemuch further and intensive
investigation in order to elucidate the impact of nerves as an
important stromal partner to PCa cells. Like several other stromal
cells, neural cells potentiate PCa aggressiveness, particularly via
(1) neurotrophic factor and autonomic neurotransmitter signal-
ing which can be proliferative, pro-angiogenetic, and pro-invasive,
(2) release of chemoattractive agents, and (3) serving as a protec-
tive, shelter path of tumor dissemination. Certainly, these features
are in part similarly observed attributes of other stromal cell types
and compartments.However,nerves and their inhabitants bear the
unique ability of combining all these features as a single partner of
interaction. Therefore, future research should not neglect the con-
tribution of nerves to PCa cell and stromal biology. The interaction
of nerves with PCa, but also with other stromal partners including
angiogenesis, desmoplasia, and cancer-associated ﬁbroblasts, is a
fascinating niche of research, and not only their abundant elec-
tric potentials, but also the major therapeutic potential imbued in
nerves in PCa deserves considerable attention.
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